Pasli Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-03-30
Clinical Trial Update: Extension to the Study of Efficacy of CDZ173 in Patients With APDS/PASLI [Phase 2, Phase 3]
Terminated extension study (Phase 2/Phase 3) evaluating CDZ173 in Activated PI3K delta syndrome (APDS) and PASLI disease; results have been …